| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-09-07 09:42:26 UTC |
|---|
| Updated at | 2022-09-07 09:42:26 UTC |
|---|
| NP-MRD ID | NP0247744 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | 4-methoxy-5-{[(2z)-5-methyl-4-pentylpyrrol-2-ylidene]methyl}-1h,1'h-2,2'-bipyrrole |
|---|
| Description | Prodigiosin belongs to the class of organic compounds known as dipyrrins. Dipyrrins are compounds containing two pyrrole rings fused via a methine (-C=) group. Prodigiosin is a secondary metabolite. Secondary metabolites are metabolically or physiologically non-essential metabolites that may serve a role as defense or signalling molecules. In some cases they are simply molecules that arise from the incomplete metabolism of other secondary metabolites. 4-methoxy-5-{[(2z)-5-methyl-4-pentylpyrrol-2-ylidene]methyl}-1h,1'h-2,2'-bipyrrole is found in Pseudoalteromonas rubra. 4-methoxy-5-{[(2z)-5-methyl-4-pentylpyrrol-2-ylidene]methyl}-1h,1'h-2,2'-bipyrrole was first documented in 2022 (PMID: 36063739). Based on a literature review a significant number of articles have been published on prodigiosin (PMID: 36048389) (PMID: 36030493) (PMID: 35992721) (PMID: 35972277) (PMID: 35956931) (PMID: 35944459). |
|---|
| Structure | CCCCCC1=C\C(=C\C2=C(OC)C=C(N2)C2=CC=CN2)N=C1C InChI=1S/C20H25N3O/c1-4-5-6-8-15-11-16(22-14(15)2)12-19-20(24-3)13-18(23-19)17-9-7-10-21-17/h7,9-13,21,23H,4-6,8H2,1-3H3/b16-12- |
|---|
| Synonyms | | Value | Source |
|---|
| 4-Methoxy-5-((5-methyl-4-pentyl-2H-pyrrol-2-ylidene)methyl)-2,2'-bipyrrole | ChEBI |
|
|---|
| Chemical Formula | C20H25N3O |
|---|
| Average Mass | 323.4400 Da |
|---|
| Monoisotopic Mass | 323.19976 Da |
|---|
| IUPAC Name | 4-methoxy-5-{[(2Z)-5-methyl-4-pentyl-2H-pyrrol-2-ylidene]methyl}-1H,1'H-2,2'-bipyrrole |
|---|
| Traditional Name | 4-methoxy-5-{[(2Z)-5-methyl-4-pentylpyrrol-2-ylidene]methyl}-1H,1'H-2,2'-bipyrrole |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CCCCCC1=C\C(=C\C2=C(OC)C=C(N2)C2=CC=CN2)N=C1C |
|---|
| InChI Identifier | InChI=1S/C20H25N3O/c1-4-5-6-8-15-11-16(22-14(15)2)12-19-20(24-3)13-18(23-19)17-9-7-10-21-17/h7,9-13,21,23H,4-6,8H2,1-3H3/b16-12- |
|---|
| InChI Key | SZXDNGVQRDTJSD-VBKFSLOCSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as dipyrrins. Dipyrrins are compounds containing two pyrrole rings fused via a methine (-C=) group. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Pyrroles |
|---|
| Sub Class | Substituted pyrroles |
|---|
| Direct Parent | Dipyrrins |
|---|
| Alternative Parents | |
|---|
| Substituents | - Dipyrrin
- Alkyl aryl ether
- Heteroaromatic compound
- Ketimine
- Ether
- Azacycle
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Organic nitrogen compound
- Organooxygen compound
- Organonitrogen compound
- Hydrocarbon derivative
- Imine
- Organopnictogen compound
- Organic oxygen compound
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Zhu G, Tan W, Xie L, Ma C, Chen X, Zhang S, Wei Y: Mechanisms underlying the inhibitory effects of Cd(2+) on prodigiosin synthesis in Serratia marcescens KMR-3. J Inorg Biochem. 2022 Nov;236:111978. doi: 10.1016/j.jinorgbio.2022.111978. Epub 2022 Aug 27. [PubMed:36063739 ]
- Alsharif KF, Albrakati A, Al Omairi NE, Almalki AS, Alsanie WF, Elmageed ZYA, Habotta OA, Lokman MS, Althagafi HA, Alghamdi AAA, Moneim AEA, Alyami H, Belal SKM, Alnefaie G, Alamri AS, Albezrah NKA, Kassab RB, Albarakati AJA, Hassan KE, Agil A: Therapeutic antischizophrenic activity of prodigiosin and selenium co-supplementation against amphetamine hydrochloride-induced behavioural changes and oxidative, inflammatory, and apoptotic challenges in rats. Environ Sci Pollut Res Int. 2023 Jan;30(3):7987-8001. doi: 10.1007/s11356-022-22409-x. Epub 2022 Sep 1. [PubMed:36048389 ]
- Saleh N, Mahmoud HE, Eltaher H, Helmy M, El-Khordagui L, Hussein AA: Prodigiosin-Functionalized Probiotic Ghosts as a Bioinspired Combination Against Colorectal Cancer Cells. Probiotics Antimicrob Proteins. 2023 Oct;15(5):1271-1286. doi: 10.1007/s12602-022-09980-y. Epub 2022 Aug 28. [PubMed:36030493 ]
- Pan X, You J, Tang M, Zhang X, Xu M, Yang T, Rao Z: Improving prodigiosin production by transcription factor engineering and promoter engineering in Serratia marcescens. Front Microbiol. 2022 Aug 3;13:977337. doi: 10.3389/fmicb.2022.977337. eCollection 2022. [PubMed:35992721 ]
- Yin L, Zhang PP, Wang W, Tang S, Deng SM, Jia AQ: 3-Phenylpropan-1-Amine Enhanced Susceptibility of Serratia marcescens to Ofloxacin by Occluding Quorum Sensing. Microbiol Spectr. 2022 Oct 26;10(5):e0182922. doi: 10.1128/spectrum.01829-22. Epub 2022 Aug 16. [PubMed:35972277 ]
- Araujo RG, Zavala NR, Castillo-Zacarias C, Barocio ME, Hidalgo-Vazquez E, Parra-Arroyo L, Rodriguez-Hernandez JA, Martinez-Prado MA, Sosa-Hernandez JE, Martinez-Ruiz M, Chen WN, Barcelo D, Iqbal HMN, Parra-Saldivar R: Recent Advances in Prodigiosin as a Bioactive Compound in Nanocomposite Applications. Molecules. 2022 Aug 5;27(15):4982. doi: 10.3390/molecules27154982. [PubMed:35956931 ]
- Abdel-Rafei MK, Thabet NM, Amin MM: Concerted regulation of OPG/RANKL/ NF‑kappaB/MMP-13 trajectories contribute to ameliorative capability of prodigiosin and/or low dose gamma-radiation against adjuvant- induced arthritis in rats. Int Immunopharmacol. 2022 Oct;111:109068. doi: 10.1016/j.intimp.2022.109068. Epub 2022 Aug 6. [PubMed:35944459 ]
- Zhang B, Yang Y, Xie W, He W, Xie J, Liu W: Identifying Algicides of Enterobacter hormaechei F2 for Control of the Harmful Alga Microcystis aeruginosa. Int J Environ Res Public Health. 2022 Jun 21;19(13):7556. doi: 10.3390/ijerph19137556. [PubMed:35805215 ]
- Paul T, Mondal A, Bandyopadhyay TK, Mahata N, Bhunia B: Downstream Process Development for Extraction of Prodigiosin: Statistical Optimization, Kinetics, and Biochemical Characterization. Appl Biochem Biotechnol. 2022 Nov;194(11):5403-5418. doi: 10.1007/s12010-022-04053-w. Epub 2022 Jul 2. [PubMed:35779175 ]
- Lazic J, Skaro Bogojevic S, Vojnovic S, Aleksic I, Milivojevic D, Kretzschmar M, Gulder T, Petkovic M, Nikodinovic-Runic J: Synthesis, Anticancer Potential and Comprehensive Toxicity Studies of Novel Brominated Derivatives of Bacterial Biopigment Prodigiosin from Serratia marcescens ATCC 27117. Molecules. 2022 Jun 9;27(12):3729. doi: 10.3390/molecules27123729. [PubMed:35744855 ]
- Islan GA, Rodenak-Kladniew B, Noacco N, Duran N, Castro GR: Prodigiosin: a promising biomolecule with many potential biomedical applications. Bioengineered. 2022 Jun;13(6):14227-14258. doi: 10.1080/21655979.2022.2084498. [PubMed:35734783 ]
- Siwawannapong K, Nemeth AM, Melander RJ, Rong J, Davis JR, Taniguchi M, Carpenter ME, Lindsey JS, Melander C: Simple Dipyrrin Analogues of Prodigiosin for Use as Colistin Adjuvants. ChemMedChem. 2022 Aug 17;17(16):e202200286. doi: 10.1002/cmdc.202200286. Epub 2022 Jul 8. [PubMed:35704751 ]
- Elkenawy NM, Karam HM, Aboul-Magd DS: Development of gamma irradiated SSD-embedded hydrogel dyed with prodigiosin as a smart wound dressing: Evaluation in a MDR infected burn rat model. Int J Biol Macromol. 2022 Jun 30;211:170-182. doi: 10.1016/j.ijbiomac.2022.05.063. Epub 2022 May 13. [PubMed:35569674 ]
- Nguyen SLT, Nguyen TC, Do TT, Vu TL, Nguyen TT, Do TT, Nguyen THT, Le TH, Trinh DK, Nguyen TAT: Study on the Anticancer Activity of Prodigiosin from Variants of Serratia Marcescens QBN VTCC 910026. Biomed Res Int. 2022 Apr 25;2022:4053074. doi: 10.1155/2022/4053074. eCollection 2022. [PubMed:35509712 ]
- Tunca Koyun M, Sirin S, Aslim B, Taner G, Nigdelioglu Dolanbay S: Characterization of prodigiosin pigment by Serratia marcescens and the evaluation of its bioactivities. Toxicol In Vitro. 2022 Aug;82:105368. doi: 10.1016/j.tiv.2022.105368. Epub 2022 Apr 25. [PubMed:35476923 ]
- LOTUS database [Link]
|
|---|